Access For All
JDRF's #AccessForAll campaign helped secure a $271.3M bipartisan commitment to subsidise Continuous and Flash Glucose Monitors for all Australians living with type 1 diabetes.
More technology for more people
Life-saving and life-changing technologies to measure blood glucose and deliver insulin in response to need are the foundation of type 1 diabetes (T1D) treatment and care in the 21st century.
JDRF believes that no Australian living with T1D should have to worry about how they will afford this technology. It is not acceptable, equitable or justifiable that access to these technologies is dictated by age or wealth rather than need and benefit.
That’s why we are thrilled JDRF’s #AccessForAll campaign helped secure a bipartisan commitment of $273.1 million for Continuous and Flash Glucose Monitors to be subsidised for all of Australia’s type 1 diabetes (T1D) community. This means that:
- CGM and Flash Glucose Monitoring devices will be available under the National Diabetes Services Scheme for those aged 21 and older who don’t already have access from 1 July 2022 for a maximum co-contribution of $32.50 per month.
- People who meet the existing eligibility criteria such as under 21s, concession card holders and pregnant women or those planning pregnancy will continue to receive unchanged, fully subsidised access to CGM and Flash Glucose Monitoring products.
The human impact
Madison, CGM user
“I can now approach my 21st birthday with pure excitement of what my future holds, free of any worry of losing access to my CGM. All of us can now have access to this technology, that has given us complete control over our type 1 diabetes”
Shanna, Flash GM user
"Knowing that I will now be able to afford my Flash Glucose Monitors each month is a huge weight off my shoulders. I know that my diabetes control will greatly improve with access to this life-saving technology.”
Daniel, CGM and pump user
”I'm so excited by the bipartisan commitment to make CGM technology affordable to all because I've seen firsthand how beneficial it will be. My control since going on the CGM early last year has been the best it has been since I was diagnosed 27 years ago and it's sensational to know the entire T1D community will see the benefits soon"
STAY UPDATED ON JDRFs ADVOCACY
Join our newsletter
Sign up to our advocacy newsletter below to receive the latest updates on how we’re working with government to create policy change and hear stories from our advocates in the T1D community.
I am interested in hearing more about…
JDRF's Latest News
How your gift can help make history: Research that’s changing the future of type 1 diabetes
Type 1 diabetes (T1D) is a condition which currently affects over 130,000 Australians, with a further 8 people diagnosed each day. JDRF has a vision of turning these numbers to zero and creating a world where T1D does not exist. How? By supporting the most promising research focused on finding cures and improving lives until […]
JDRF advocate Shanna McGrath receives Mark Butler Local Legend Award
Each year during National Volunteers Week, the Minister for Health, Hon Mark Butler, announces the winners of the Mark Butler MP Volunteer Awards. These awards recognise the local volunteers in his electorate, Hindmarsh, who are dedicated to improving the needs of the community organisations they represent. JDRF advocate, Shanna McGrath, was diagnosed with T1D when […]
Our 2023 Volunteer of the Year winners
It’s National Volunteer Week and this year’s theme is ‘change makers’. At JDRF, we know that no change for type 1 diabetes (T1D) has happened without the dedication of volunteers across the community. We are an organisation who was founded by volunteers and is still powered by them, including (but not limited to!) our amazing […]
Dr Ki Wook Kim awarded JDRF Career Development Award to improve type 1 diabetes risk prediction
Dr Ki Wook Kim, a prominent Australian researcher and emerging leader in type 1 diabetes (T1D) research based at the UNSW Sydney, has been awarded a JDRF Career Development Award (CDA) with US $1M funding committed over the next five years. Dr Kim is one of only 13 Australians to ever receive the JDRF Career […]
Insulin Pump Program extended to 21 years of age
The Federal Government’s Insulin Pump Program (IPP), administered by JDRF, operates to ensure children and young adults with type 1 diabetes (T1D) who do not have the means to access a pump, have a pathway to be able to use the life-changing management technology. The IPP was established in 2008 and initially provided insulin pumps […]
Drug Verapamil shown to slow T1D progression in newly diagnosed
A new study has shown drug Verapamil, regularly used to treat blood pressure, can slow type 1 diabetes progression in newly diagnosed children and teens. As researchers work to cure type 1 diabetes (T1D), the ultimate goal is to prevent the destruction of beta cells that produce insulin. A new JDRF-funded clinical trial reveals a […]
$12M invested to progress landmark ENDIA study
MEDIA RELEASE Australia leading type 1 diabetes research with $12M invested to progress landmark study The funding will support the extension of ENDIA, a world-first study seeking to understand the role of environmental triggers from as early as pregnancy for the onset of type 1 diabetes (T1D). 4 April 2023: JDRF Australia and funding partner […]
Parties, special events, and your child’s type 1 diabetes
There’s no doubt that parties and special occasions can be a stressful experience for T1D parents, especially with younger children or those who have been recently diagnosed. Tables of party food and lots of excitement and activity can be a tricky combination when it comes to keeping blood glucose levels (BGLs) in range. But it’s […]
Travelling with type 1 diabetes: navigating common challenges
Travelling with type 1 diabetes can be fun and safe – and with a little preparation, you’ll have peace of mind that you’ll be able to tackle any eventuality that arises. How to travel with type 1 diabetes Hopping on a plane, a ship or in the car to travel away from home is a […]